An efficient design for phase III studies of combination chemotherapies

Cancer Treat Rep. 1985 Oct;69(10):1147-54.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Clinical Trials as Topic / methods
  • Clinical Trials as Topic / standards*
  • Humans
  • Neoplasms / drug therapy*
  • Probability
  • Random Allocation
  • Research Design
  • Sampling Studies
  • Statistics as Topic